Patient description: The patient is a 34-year-old obese woman who comes to the clinic with weight concerns. She is 165 cm tall, and her weight is 113 kg (BMI: 41.5). In the past, she unsuccessfully used antiobesity agents and appetite suppressants. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher. She is married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She rarely exercises and movement seems to be hard for her. She is not able to complete the four-square step test in less than 15 seconds. She does not smoke or use any drugs. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her lab results: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl She is considering a laparoscopic gastric bypass.

Clinical trial eligibility criteria: eligible ages (years): 24.0-60.0,  Body Fat Male or Female, 24 to 60 years of age (inclusive) 2. Fitzpatrick Skin Type I VI (Appendix 3) 3. Has visible fat bulges or skin laxity in the abdominal region 4. Scheduled to undergo surgery (abdominoplasty). 5. Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study. 6. Subject must agree to not undergo any other procedure(s) in the abdominal region during the study period. 7. Subject must be able to read, understand and sign the Informed Consent Form. 8. Subject must adhere to the follow-up schedule and study instructions. 9. Subject must adhere to the same diet/ exercise/medication regimen for the entire course of the study. 10. Willing to provide histology samples during the surgery from the intended to be harvested areas. 11. Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, and no plans to become pregnant  Participation in a clinical trial of another device or drug in the target area during the study period. 2. Any type of prior cosmetic treatment to the target area within 12 months of study participation e.g., radiofrequency, cryolysis or light-based treatments. 3. Any prior invasive cosmetic surgery to the target area, such as liposuction. 4. Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant. 5. Has metal implant(s) within the body, such as surgical clips, plates and screws, intrauterine device (IUD), artificial heart valves or artificial joints. 6. Significant concurrent illness, such as diabetes mellitus, cardiovascular disease, peripheral vascular disease or pertinent neurological disorders. 7. Diagnosed or documented immune system disorders. 8. History of any disease or condition that could impair wound healing. 9. History of diseases stimulated by heat, such as recurrent herpes zoster in the treatment area, unless treatment is conducted following a prophylactic regimen. 10. History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing in the treatment area. 11. Infection, dermatitis, rash or other skin abnormality in the target area. 12. Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation. 13. Pregnant or currently breastfeeding. 14. As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study